Mark Roithmayr

Mark Roithmayr serves as Chief Executive Officer at Alzheimer's Drug Discovery Foundation. Alzheimer's Drug Discovery Foundation operates in the research sector with approximately 69.0 employees. The company is headquartered in New York, New York. Alzheimer's Drug Discovery Foundation generates annual revenue of 7319000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 6,952 executive contacts are available in New York.
• • Our database includes 201,469 c suite-level executives.

Route 53 Outlook MailChimp SPF Microsoft Office 365 DigitalOcean Hubspot Webflow Facebook Login (Connect) YouTube Typekit Google Analytics MailChimp Nginx Ubuntu Facebook Custom Audiences Facebook Widget Bootstrap Framework Mobile Friendly Google Tag Manager reCAPTCHA Remote IoT

neuroscience drug discovery biomarker development cognitive aging research services alzheimer's disease biomarker research clinical trials venture philanthropy diagnosis treatment prevention alzheimer's research cognitive vitality drug development drugs to prevent alzheimer's scaling blood tests diagnostics accelerator biomarker programs aging biology neuroinflammation vascular health amyloid plaques early detection aduhelm amyvid pet scan neuro motor index retrieving funding philanthropic investments research strategy patient resources family support age-related disorders value-based care collaborative research translational medicine healthcare innovation immunotherapy precision medicine dementia longitudinal studies scientific partnerships patient outcomes regulatory affairs research grants academic collaborations clinical evaluation fundraising events community engagement non-profit organization therapeutic development diagnostic techniques neurodegenerative diseases nonprofit organization innovative research biomarkers diagnostics healthcare professionals academic research pharmaceutical industry funding model global reach early-stage research high-risk projects treatment solutions patient care caregiver support vascular dysfunction misfolded proteins clinical development portfolio innovative funding strategies collaborative partnerships alzheimer's advocacy cognitive health aging research biotechnology health care health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

How can I contact Mark Roithmayr?

Mark Roithmayr's verified email address is available on MessageCEO. They currently work at Alzheimer's Drug Discovery Foundation. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Mark Roithmayr lead?

Mark Roithmayr is Chief Executive Officer at Alzheimer's Drug Discovery Foundation, a company in the research sector with 69.0 employees. The company is based in New York, New York.

What industry is Mark Roithmayr in?

Mark Roithmayr works in the research industry as Chief Executive Officer at Alzheimer's Drug Discovery Foundation. MessageCEO provides verified contact information for executives across all major industries.

Is Mark Roithmayr's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Mark Roithmayr's profile is kept up-to-date with the latest available information.

Last updated: April 8, 2026